Streetbeat News

Stock Prices

DKNG

The Detroit Pistons set an NBA record with 27 consecutive losses, the worst start in the league at 2-28. Despite Cade Cunningham's strong performance, the team's losing streak has become a major story. Betting against the Pistons could have turned a $100 bet into $789,995.95. DraftKings Inc (NASDAQ:DKNG) has set the Pistons' season win total over/under at 9.5 and offers bets on their next win, with a bettor placing a $40 wager on the Pistons not winning another game at +100,000 odds.

Portfolio Pulse from Chris Katje

December 27, 2023 | 8:10 pm

GM

General Motors (NYSE:GM) has seen a decrease in short interest, with the short percent of float dropping 18.57% since the last report. The company has 26.31 million shares sold short, representing 1.93% of available shares. The current short interest suggests it would take about 1.0 trading day to cover all short positions. A decrease in short interest can indicate a more bullish sentiment towards the stock, although it does not guarantee a price increase. GM's short interest is below its peer group average of 13.13%.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 8:00 pm

AVGO

Broadcom Inc. (NYSE:AVGO) has seen a significant decrease in short interest, with a 27.17% drop since the last report. The current short interest stands at 4.73 million shares, or 1.26% of the float, with a short-covering time of 1.25 days. This decline in short interest may indicate a more bullish sentiment among investors compared to the peer group average of 3.70% short interest as a percentage of float.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 8:00 pm

MU

Micron Technology (NYSE:MU) has seen a decrease in short interest, with the short percent of float dropping 5.88% since the last report. The company has 19.38 million shares sold short, representing 1.76% of available shares, with a cover time of 1.57 days. This decline in short interest may indicate a more bullish sentiment among investors, although it does not necessarily predict a near-term price rise. Micron's short interest is below its peer group average of 3.68%.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 8:00 pm

BN

Brookfield's (NYSE:BN) short interest has decreased by 4.4%, with 25.74 million shares sold short, representing 1.74% of its float. It would take about 12.36 days to cover all short positions. A decrease in short interest can indicate a more bullish sentiment towards the stock. Brookfield has less short interest compared to its peer group average of 3.31%. Short interest is a key indicator of market sentiment and can influence stock price movements.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 7:45 pm

HSBC

HSBC Holdings (NYSE:HSBC) has seen a 5.26% increase in short interest since the last report, with 7.97 million shares sold short, representing 0.2% of available shares. It would take about 4.28 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a price drop. HSBC's short interest is below its peer group average of 0.83%.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 7:45 pm

QCOM

Qualcomm's (NYSE:QCOM) short interest has decreased by 17.9% since the last report, with 14.82 million shares sold short, representing 1.33% of available shares. The average time to cover these short positions is 1.66 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Qualcomm's short interest is below its peer group average of 3.70%.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 7:45 pm

DHI

D.R. Horton Inc. (NYSE:DHI) stock is currently priced at $150.70, experiencing a slight drop of 0.01%. Despite this, the stock has seen a significant increase of 19.17% over the past month and 69.64% over the past year. The P/E ratio, a key indicator of valuation, shows D.R. Horton with a lower P/E than the Household Durables industry average, suggesting it might be undervalued or expected to perform worse than its peers. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for a comprehensive investment decision.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 7:30 pm

HUMA

Benchmark analyst Bruce Jackson has maintained a Buy rating on Humacyte (NASDAQ:HUMA) but has reduced the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 7:23 pm

BJDX

CHRS

CYTK

FWBI

HALL

IOVA

U.S. stocks traded mixed with the Dow slightly up and the S&P 500 and Nasdaq Composite slightly down. Crude oil prices fell by 1.4%, while gold and silver prices rose. First Wave BioPharma's stock spiked after announcing a potential sale of its Niclosamide program. Cytokinetics surged following positive trial results, and Coherus BioSciences gained on FDA approval news. Conversely, Hallmark Financial Services, Bluejay Diagnostics, and Iovance Biotherapeutics saw significant stock declines due to various company-specific news.

Portfolio Pulse from Avi Kapoor

December 27, 2023 | 7:19 pm